Simcere Pharmaceutical Group (HKG:2096) agreed to grant over 15.4 million restricted share units (RSUs) to 97 participants under a 2021 incentive scheme, a Monday Hong Kong bourse filing said.
Shares of the pharmaceutical firm were down nearly 4% in Tuesday afternoon trading.
The RSUs represent the same number of underlying shares.
The grantees include certain executive directors, members of the senior management, and 92 other employees.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.